Work in the Kebede laboratory is supported by Diabetes Australia Research Trust and the National Health and Medical Research Council of Australia
Wild-type ( Glp1r +/+ ), heterozygous and homozygous littermates were phenotypically normal and possessed similar body weights (Fig
The investment in broad label clinical evidence, which typically means running additional arms in pivotal trials or supplementary studies to capture data across patient subgroups, pays compound returns through the commercial access period
GHK-Cu vs NAD+ head-to-head comparison
has acted as a speaker for Novo Nordisk and has received grants from Novo Nordisk, Novo Nordisk UK Research Foundation, Academy of Medical Sciences/ Diabetes UK and Health Education East Midlands
Salminen, A., Hyttinen, J